Skip to main content
Clinical Trials/NCT07211828
NCT07211828Not yet recruitingNot Applicable

Pharmacodynamic Effects of Propofol and Alfentanil on EEG During Endoscopic Retrograde Cholangiopancreatography (ERCP)

Chi Kwan Fung0 sites20 target enrollmentStarted: October 10, 2025Last updated:
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
20
Primary Endpoint
EEG alpha power to beta power ratio

Study Overview

Brief Summary

Recording and analyzing electroencephalogram (EEG) and continuous pain monitor data under anesthesia in order to investigating the pharmacodynamic effects of opioids and sedatives.

Detailed Description

The Patient State Index (PSI) is the main instrument used for monitoring brain waves during anesthesia. By using conductive patches to detect frontal lobe brainwave patterns, PSI helps assess the patient's depth of anesthesia. The Analgesia Nociception Index (ANI) is a heart rate variability (HRV)-based indicator that evaluates the activity of the autonomic nervous system (sympathetic and parasympathetic), thereby reflecting the patient's pain or stress response. PSI and ANI are often used together in anesthetized patients to avoid drug overdose.

Since opioids and sedative drugs interact with each other, different doses of opioids and sedatives have varying effects on brain waves, PSI, and ANI. This interaction has recently become a focus in anesthesiology and critical care medicine.

The purpose of this study is to use target-controlled infusion (TCI) to continuously administer opioids and sedative drugs, and to observe changes in the Patient State Index (PSI), raw EEG, and ANI data during the anesthesia process, in order to identify the effects of opioids and sedatives on PSI, EEG, and ANI.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Double (Participant, Care Provider)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients who under go ERCP who require general anesthesia

Exclusion Criteria

  • ASA> or = 4 , vulnerable groups such as prisoners, patients with physical or mental disabilities and HIV carriers

Arms & Interventions

Sedation with high dose of alfentanil with the presence of propofol

Experimental

Adjust dose of alfentanil until reaching to the upper limit before adjusting dose of propofol. This aims to have a highest dose of alfentanil during anesthesia.

Intervention: high dose of alfentanil (Drug)

Sedation with low dose of alfentanil with the presence of propofol

Active Comparator

Adjust dose of propofol to the upper limit before adjusting dose of alfentanil. This aims to have alfentanil less or equal to 10ng/mL during anesthesia.

Intervention: low dose of alfentanil with propofol (Drug)

Outcomes

Primary Outcomes

EEG alpha power to beta power ratio

Time Frame: Baseline and periprocedural

EEG alpha ratio

Time Frame: baseline and periprocedural

EEG delta ratio

Time Frame: baseline and periprocedural

EEG beta ratio

Time Frame: baseline and periprocedural

Patient State Index (PSI)

Time Frame: baseline and periprocedural

A processed electroencephalogram (EEG) parameter derived from frontal EEG signals. It is being measured continuously by a EEG monitor.

Secondary Outcomes

  • Analgesia Nociception Index (ANI)(Baseline and periprocedural)
  • Blood pressure(baseline and periprocedural)
  • Non-invasive cardiac output(during the whole sedation)
  • Heart rate(baseline and periprocedural)
  • Peripheral Capillary Oxygen Saturation (SpO₂)(baseline and periprocedural)
  • Non-invasive cardiac index(baseline and periprocedural)
  • Non-invasive Stroke Volume (SV)(baseline and periprocedural)

Investigators

Sponsor
Chi Kwan Fung
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Chi Kwan Fung

Attendant Physician

China Medical University Hospital

Similar Trials